UnknownNot Applicable

Evaluating Infrasonic Hemodynography

United States25 participantsStarted 2021-01-04

Plain-language summary

This comparative diagnostic accuracy study will determine the accuracy of a noninvasive wearable infrasonic sensor to detect the mechanical, electrical, and hemodynamic function of the cardiovascular system.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Normal Sinus Rhythm * LV systolic function \>53% Exclusion Criteria: * 1\. Known history of carotid artery disease * 2\. Moderate or greater valvular disease in Group 1 * 3\. Other implantable devices (pacemaker, ICD, CardioMems, TENS unit, continuous glucose monitors, etc) * 4\. Active arrhythmia * 5\. Reduced Ejection Fraction (\< 35%) other than Group 4 * 6\. Hearing loss

What they're measuring

Infrasound Hemodynography

Timeframe: 1 year

Trial details

NCT IDNCT04636892

SponsorScripps Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-01

Contact for this trial

Carly Waldman, MD

858-537-7792 waldman.carly@scrippshealth.org

View on ClinicalTrials.gov More Aortic Stenosis trials